We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
The Quigley (MM) | NASDAQ:QGLY | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 1.8501 | 0 | 01:00:00 |
The name change was one of five proposals overwhelmingly approved by a substantial majority of the shareholders who voted. The other four proposals include:
"The vote was a culmination and affirmation of more than a year of very hard work," said CEO Ted Karkus. "The shareholder support for our team is very much appreciated. Our new identity sets the stage for a new growth phase for our Company by improving our image with our important retailers as well as with investors."
The roll-out of the corporate identity change to "ProPhase Labs" will occur over the next 6-8 weeks. Other aspects of the new corporate name and identity will include a new corporate logo, and improved product Cold-EEZE®, and Kids-EEZE® packaging.
About The Quigley Corporation
The Quigley Corporation is a diversified natural health medical science company. It is a leading marketer and manufacturer of the Cold-EEZE® family of lozenges and sugar free tablets clinically proven to significantly reduce the severity and duration of the common cold. Cold-EEZE® customers include leading national wholesalers and distributors, as well as independent and chain food, drug and mass merchandise stores and pharmacies. The Quigley Corporation has several wholly owned subsidiaries including Quigley Manufacturing Inc., which consists of an FDA approved facility to manufacture Cold-EEZE® lozenges and fulfill other contract manufacturing opportunities, and Quigley Pharma, Inc., which conducts research in order to develop and commercialize a pipeline of patented botanical and naturally derived potential prescription drugs.
Forward-Looking Statements
Certain statements in this press release are "forward-looking statements" and involve known and unknown risk, uncertainties and other factors that may cause the Company's actual performance or achievements to be materially different from the results, performance or achievements expressed or implied by the forward-looking statement. Factors that impact such forward-looking statements include, among others, changes in worldwide general economic conditions; government regulations; the ability of our new management to successfully implement our business plan and strategy; our ability to fund our operations including the cost and availability of capital and credit; our ability to compete effectively including our ability to maintain and increase our market share in the markets in which we do business; and our dependence on sales from our main product, Cold-EEZE®, and our ability to successfully develop and commercialize new products.
CONTACT Media Relations The Lexicomm Group Wendi Tush Email Contact (212) 794-4531 Lindsey Gardner Email Contact (570) 479-4895 Investor Relations Ted Karkus Chairman and CEO The Quigley Corporation (215) 345-0919 x 0
1 Year The Quigley (MM) Chart |
1 Month The Quigley (MM) Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions